期刊文献+

MiR-20a在肿瘤中相关作用机制的研究进展 被引量:3

Research progress on the mechanism of miR-20a in tumor
原文传递
导出
摘要 MiR-20a是miR-17-92簇家族中的一个非编码RNA,靶向目的mRNA从而发挥转录后基因表达的调控功能,但在不同类型的肿瘤进展中发挥的作用不尽相同,提示miR-20a可能是一种细胞或组织特异性miRNA。近年来,研究人员利用生物信息学方法预测miR-20a的靶基因,并进行蛋白质表达验证,进而判断其所在的肿瘤调控信号通路,将miRNA的研究拓展到肿瘤标志物、耐药研究及预后因子等临床应用上来。本文就miR-20a在多种癌症中的作用机制,及其在临床诊断和应用中的进展作一综述,为肿瘤的分子生物学机制研究提供理论依据。 MiR-20a is a non-coding RNA in the miR-17-92 cluster,and plays a regulatory role in posttranscriptional gene expression by aim to target mRNA.However,miR-20a plays different roles in different types of tum or progression,so it may be a cellular or tissue specific miRNA.In recent years,researchers predicted m iR-20a target genes by bioinform atics m ethods.And determ ined the location of the tum or regulatory signaling pathways by verifing the protein expression.The researches of m iRNA is extended to the clinical application of tum or markers,drug resistance and prognostic factors.This article reviews the mechanism of mir-20a in various cancers and its developm ent in clinical diagnosis and application,and provides theoretical basis for the study of molecular biological mechanism of tumors.
作者 王晛珏 苏丽娅 WANG Xianjue;SU Liya(Clinical Medical Research of the Affiliated Hospital,Inner Mongolia Medical University,Huhhot 010050,China)
出处 《生命的化学》 CAS CSCD 2020年第12期2207-2215,共9页 Chemistry of Life
基金 内蒙古自治区高等学校“青年科技英才支持计划”(NJYT-19-A17) 内蒙古医科大学附属医院重大项目(NYFYZD017) 内蒙古教育厅高等学校科学研究项目(NJZY20139) 内蒙古医科大学青年创新基金项目(YKD2018QNCX090)。
关键词 miR-20a 肿瘤 信号通路 临床诊断 预后 miR-20a tumor signal pathway clinical diagnosis prognosis
  • 相关文献

参考文献1

二级参考文献41

  • 1Du T, Zamore PD. microPrimer: the biogenesis and function ofmicroRNA. Development, 2005, 132(21): 4645-4652.
  • 2Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2): 281-297.
  • 3Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res, 2008, 79(4): 581-588.
  • 4Blenkiron C, Miska EA. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet, 2007,16(1): 106-113.
  • 5He L, Thomson JM, Hemann MT, Hemando-monge E, Mu D, Goodson S, Powers S, Cordon-cardo C, Lowe SW, Harmon G J, Hammond SM. A microRNA polycistron as a potential human oncogene. Nature, 2005, 435(7043): 828-833.
  • 6Landais S, Landry S, Legault P, Rassart E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res, 2007, 67(12): 5699-5707.
  • 7Ventura A, Young AG, Winslow MM, Lintault L, Meissher A, Erkeland S J, Newman J, Bronson RT, Crowley D,Stone JR, Jaenisch R, Sharp PA, Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell, 2008, 132(5): 875-886.
  • 8Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T Kanellopoulou C, Jensen K, Cobb BS, Merkenschlager M, Rajewsky N, Rajewsky K. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell, 2008, 132(5): 860-874.
  • 9Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol, 2007, 310(2): 442-453.
  • 10Lu Y, Okubo T, Rawlins E, Hogan BL. Epithelial progenitor cells of the embryonic lung and the role of microRNAs in their proliferation. Proc Am Thorac Soc, 2008, 5(3): 300-304.

共引文献13

同被引文献27

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部